Delivery Order SPE2DB20D2014-SPE2DB24FD05S

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,739.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of Myrbetriq ER 25 mg tablets. The award is not set aside and has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of medical commodities, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 25 mg tablets. The $22,669.80 firm-fixed-price contract has an ultimate completion date of August 19, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice to provide a wide range of medical commodities, including prescription drugs and medical supplies, to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 25 mg tablets. The $12,672.39 firm fixed-price contract has a completion date of May 12, 2025 and is not set aside. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,350.57, is for the supply of Myrbetriq ER 50 MG tablets. The order has an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Myrbetriq ER 25 mg tablets. The contract has a ceiling value of $2,669.34 and a period of performance through July 31, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $23,017.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The contract has an ultimate completion date of May 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply Myrbetriq ER 25 mg tablets. The $3,464.61 firm-fixed-price contract has an ultimate completion date of August 28, 2024. AmerisourceBergen holds several significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice to provide a wide range of pharmaceutical and medical supplies to support military and federal...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,883.87 firm fixed-price contract is for the supply of Myrbetriq ER 25 mg tablets. The award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC enables the company to provide a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The $3,800.30 firm fixed-price contract has an ultimate completion date of September 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Myrbetriq ER 50 mg tablets. The contract is a firm-fixed price delivery order with a ceiling value of $4,533.41 and a completion date of September 11, 2024. The contract is not designated as a set-aside. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD05S
    Delivery Order

This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Myrbetriq ER 25 mg tablets. The contract, valued at $5,779.77, has a period of performance through September 18, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, enabling the efficient procurement of essential pharmaceutical and medical products to support government healthcare programs and facilities nationwide. This award is not associated with a set-aside program.

Generated 12/17/24, 9:21 AM